Samsara BioCapital as of March 31, 2026
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 22 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 32.9 | $339M | 6.9M | 49.16 | |
| Mineralys Therapeutics (MLYS) | 15.5 | $159M | 5.9M | 27.09 | |
| Alumis (ALMS) | 13.6 | $140M | 6.3M | 22.03 | |
| Septerna (SEPN) | 7.4 | $76M | 3.1M | 24.03 | |
| Kalaris Therapeutics (KLRS) | 7.3 | $75M | 13M | 5.77 | |
| Spyglass Pharma Com Shs | 5.3 | $55M | 2.1M | 25.91 | |
| Neurogene (NGNE) | 3.4 | $35M | 1.7M | 20.16 | |
| Inventiva Sa Ads (IVA) | 2.8 | $29M | 5.2M | 5.55 | |
| Sutro Biopharma Com Shs (STRO) | 2.6 | $27M | 1.1M | 24.91 | |
| Jade Biosciences Com New (JBIO) | 1.3 | $14M | 969k | 14.05 | |
| Vtv Therapeutics Cl A New (VTVT) | 1.2 | $12M | 299k | 39.66 | |
| Aquestive Therapeutics (AQST) | 1.0 | $10M | 2.5M | 4.15 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.7 | $7.6M | 1.8M | 4.13 | |
| Nkarta (NKTX) | 0.7 | $7.4M | 3.5M | 2.11 | |
| Arcellx Common Stock (ACLX) | 0.7 | $7.0M | 61k | 114.82 | |
| Upstream Bio (UPB) | 0.6 | $6.6M | 736k | 9.00 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.6 | $6.3M | 57k | 111.35 | |
| Agomab Therapeutics Nv Sponsored Ads | 0.6 | $6.3M | 600k | 10.49 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.6 | $6.2M | 8.5M | 0.73 | |
| Coherus Biosciences (CHRS) | 0.6 | $5.8M | 3.4M | 1.69 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.5 | $4.8M | 38k | 124.65 | |
| Gossamer Bio (GOSS) | 0.2 | $2.4M | 7.2M | 0.33 |
